3B BlackBio Dx Ltd

NSE: 3BBLACKBIO · BSE: 532067 · Chemicals & Petrochemicals · 19 announcements

Share price: ₹1,576.20
Market cap: ₹1,353 Cr
Revenue (annual): ₹141.9 Cr
Net profit (annual): ₹58.59 Cr
P/E (TTM): 24.4×Sector 37.2×
Promoter holding: 40.95%+0.01% QoQ
FII holding: 2.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 4 Other Announcement 3 Financial Results 3 Debt & Borrowing 2 Board Meeting Date 2 Promoter Buying 1 Legal & Regulatory 1 Capital Structure Change 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

13 Aug 2026 16:09 IST BSE

Financial Results

3B BlackBio Dx Q1 FY27 Results: Net Profit ₹9 Cr, Down 28.6% YoY

3B BlackBio Dx Ltd reported revenue from operations of ₹33.5 Cr (+50.9% YoY) and net profit of ₹9 Cr (-28.6% YoY) for Q1 FY27.

Key figure: Net profit ₹9 Cr · -28.6% YoY

Open full results → Read the filing ↗

29 May 2026 15:43 IST BSE

Financial Results

3B BlackBio Dx Q4 FY26 Results: Net Profit ₹9.8 Cr, Up 22.5% YoY

3B BlackBio Dx Ltd reported revenue from operations of ₹35.4 Cr (+57.3% YoY) and net profit of ₹9.8 Cr (+22.5% YoY) for Q4 FY26.

Key figure: Net profit ₹9.8 Cr · +22.5% YoY

Open full results → Read the filing ↗

29 May 2026 15:43 IST BSE

Financial Results

3B BlackBio Dx Financial Results

3B BlackBio Dx reported FY2026 financial results and recommended a Rs. 5.00 per share dividend. The company also appointed M/s Ali Jain & Sharma as internal auditors.

Value: ₹0.43 Cr

Read the filing ↗